Heron Bay Capital Management’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-1,034
| Closed | -$743K | – | 108 |
|
|
2023
Q2 | $743K | Buy |
1,034
+11
| +1% | +$7.9K | 0.21% | 52 |
|
|
2023
Q1 | $841K | Buy |
+1,023
| New | +$841K | 0.33% | 48 |
|
|
2022
Q1 | – | Sell |
-3,686
| Closed | -$2.33M | – | 73 |
|
|
2021
Q4 | $2.33M | Buy |
3,686
+42
| +1% | +$26.5K | 1.15% | 37 |
|
|
2021
Q3 | $2.21M | Buy |
3,644
+955
| +36% | +$578K | 1.14% | 32 |
|
|
2021
Q2 | $1.5M | Buy |
2,689
+59
| +2% | +$33K | 0.83% | 43 |
|
|
2021
Q1 | $1.24M | Buy |
2,630
+464
| +21% | +$219K | 0.74% | 47 |
|
|
2020
Q4 | $1.05M | Buy |
+2,166
| New | +$1.05M | 0.68% | 49 |
|